Emmaus Life Sciences, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative)

STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)					1 Months Ended					12 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($)	Jan. 27, 2023	Jan. 12, 2023	Jun. 15, 2020	Dec. 29, 2017	Dec. 31, 2023	Nov. 30, 2023	Jan. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022	Apr. 30, 2023	Dec. 31, 2021	Sep. 29, 2021	Feb. 09, 2021	Dec. 31, 2020	Dec. 31, 2018
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount					$ 29,946,000					$ 29,946,000	$ 27,562,000
Change in fair value of warrant derivative liabilities										1,195,000	1,304,000
Warrants granted, term		5 years						5 years
Warrants granted to purchase common stock		7,500,000						500,000
Warrant derivative liability					65,000					65,000	70,000
Change in fair value of derivative liabilities										$ 1,200,000
Weighted average remaining contractual life (years), outstanding										2 years 1 month 6 days
Share-based compensation										$ 1,262,000	16,000
Research and development										1,189,000	1,725,000
Common stock issued for services											119,000
Warrant excercise price		$ 4.5						$ 2.5
Reclassification of warrants from liability to equity											$ 213,000
Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Common stock issued for services (in shares)											271,637
Common stock issued for services											$ 1,000
Additional Paid-in Capital [Member]
Class Of Warrant Or Right [Line Items]
Common stock issued for services											118,000
Reclassification of warrants from liability to equity						$ 296,000					$ 213,000
General and Administrative Expense [Member]
Class Of Warrant Or Right [Line Items]
Share-based compensation										1,200,000
Aggregate estimated granted warrants					$ 334,000					$ 334,000
Amended and Restated Warrants [Member]
Class Of Warrant Or Right [Line Items]
Number of common stock to be purchased										2,381,300
Adjustment of warrants change in fair value increase additional paid in capital and accumulated loss									$ 446,000
Warrant excercise price									$ 0.446
Professional Relations and Consulting Service [Member]
Class Of Warrant Or Right [Line Items]
Warrants granted, term	5 years	5 years
Warrants granted to purchase common stock		250,000
Warrant expired date		2023-11
Warrant excercise price	$ 0.47	$ 0.5
Professional Relations and Consulting Service [Member] \| Maximum [Member]
Class Of Warrant Or Right [Line Items]
Warrants granted to purchase common stock	500,000
Restricted Stock [Member] \| Professional Relations and Consulting Service [Member] \| Common Stock [Member]
Class Of Warrant Or Right [Line Items]
Common stock issued for services (in shares)									246,637
Common stock issued for services									$ 110,000
2011 Stock Incentive Option Plan [Member] \| Stock Options [Member]
Class Of Warrant Or Right [Line Items]
Vesting period										3 years
Exercisable/expiration period										10 years
Expiration date										2021-05
Stock option awards outstanding					1,728,773					1,728,773	4,412,940
Number of shares authorized under the plan																	9,000,000
2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Total unrecognized compensation cost					$ 94,000					$ 94,000
Options granted										1,250,000
Vesting period										2 years
Exercisable/expiration period										10 years
Stock option awards outstanding					1,250,000					1,250,000	0
2021 Stock Incentive Option Plan [Member] \| Stock Options [Member]
Class Of Warrant Or Right [Line Items]
Number of shares authorized under the plan														4,000,000
2011 and 2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Share-based compensation										$ 1,262,000	$ 16,000
Stock option awards outstanding					3,223,881					3,223,881	4,660,787		5,968,338
2011 and 2021 Stock Incentive Option Plan [Member] \| Warrants Issued [Member]
Class Of Warrant Or Right [Line Items]
Share-based compensation										$ 1,151,000
2011 and 2021 Stock Incentive Option Plan [Member] \| Stock Options [Member]
Class Of Warrant Or Right [Line Items]
Share-based compensation										$ 111,000
2012 Omnibus Incentive Compensation Plan [Member]
Class Of Warrant Or Right [Line Items]
Stock option awards outstanding					245,108					245,108	247,847
Dr. Yutaka Niihara [Member]
Class Of Warrant Or Right [Line Items]
Change in fair value of warrants											$ 14,000
Employees [Member] \| 2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Options granted										850,000
Black-Scholes Merton model [Member]
Class Of Warrant Or Right [Line Items]
Warrant derivative liability											70,000
Non-Employee Director [Member] \| 2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Options granted										300,000
Vesting period										1 year
Consultant [Member] \| 2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Options granted										100,000
Employee Director [Member] \| 2021 Stock Incentive Option Plan [Member]
Class Of Warrant Or Right [Line Items]
Vesting period										3 years
Convertible Promissory Note [Member]
Class Of Warrant Or Right [Line Items]
Adjustment of warrants change in fair value increase additional paid in capital and accumulated loss					$ 11,000		$ 41,000
Warrant excercise price					$ 0.29		$ 0.37			$ 0.29
Convertible Promissory Note [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount			$ 3,150,000
Convertible notes aggregate purchase price							$ 500,000					$ 1,000,000
Change in fair value of warrant derivative liabilities											1,300,000
Extended maturity date			Jun. 15, 2023
Expected life (in years)			5 years
Number outstanding			1,250,000
Outstanding shares repayment			500,000
Percentage of monthly payments interest rate			12.00%												2.00%	11.00%
Warrant excercise price			$ 2.05
Repayment of debt			$ 0
Convertible Promissory Note [Member] \| Maximum [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes aggregate purchase price															$ 17,000,000
Senior Secured Convertible Promissory Note [Member] \| GPB Debt Holdings II, LLC [Member] \| Securities Purchase Agreement [Member]
Class Of Warrant Or Right [Line Items]
Convertible notes principal amount				$ 13,000,000
Convertible notes aggregate purchase price				$ 12,500,000
Original issue discount percentage				4.00%
Initial warrants exercisable period after issuance				5 years
Change in fair value of warrant derivative liabilities											$ 40,000,000
Warrant expiration date				2022-06
Warrants granted to purchase common stock				240,764
Warrant excercise price				$ 10.8